ArticleLeukemia research2017
The eIF2-alpha kinase HRI is a novel therapeutic target in multiple myeloma.
Nicholas Burwick et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
21 papers cite it
this papercites it
ArticleLeukemia research2017
Nicholas Burwick et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.